SAFETY AND EFFECTIVENESS OF PEMETREXED IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN JAPAN BASED ON POST-MARKETING SURVEILLANCE

被引：0
|
作者：
Okubo, Sumiko [1 ]
Kobayashi, Noriko [1 ]
Taketsuna, Masanori [1 ]
Enatsu, Sotaro [1 ]
Nishiuma, Shinichi [1 ]
机构：
[1] Eli Lilly Japan, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
Post-Marketing Surveillance; NSCLC; Pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-011
引用
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [1] Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
    Sharareh Seifi
    Babak Salimi
    Zahra Esfahani Monfared
    Cyrus Sabahi
    Hamidreza Kafi
    Adnan Khosravi
    [J]. Journal of Pharmaceutical Policy and Practice, 16
  • [2] Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
    Seifi, Sharareh
    Salimi, Babak
    Monfared, Zahra Esfahani
    Sabahi, Cyrus
    Kafi, Hamidreza
    Khosravi, Adnan
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [3] Real-world outcomes of pembrolizumab monotherapy in non-small cell lung cancer in Japan: A post-marketing surveillance
    Yamamoto, Nobuyuki
    Kamitani, Tetsu
    Kanda, Kingo
    Ito, Yuichiro
    Hamada, Masahiro
    Ozaki, Masahiko
    Takeuchi, Noriko
    Yamada, Tomoko
    Kawano, Masaki
    Maekawa, Shinichiroh
    Kato, Terufumi
    [J]. CANCER SCIENCE, 2022, 113 (09) : 3110 - 3119
  • [4] Real-world safety of nivolumab in patients with non-small cell lung cancer (NSCLC) in Japan: Interim summary of post-marketing all-case surveillance
    Ohe, Y.
    Gemma, A.
    Nakagawa, K.
    Yamamoto, N.
    Saito, T.
    Akamatsu, A.
    Kuwano, K.
    Nakanishi, Y.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [5] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    [J]. CHEMOTHERAPY, 2007, 53 (02): : 85 - 103
  • [6] Safety and effectiveness of avelumab in patients with Merkel cell carcinoma in general clinical practice in Japan: Post-marketing surveillance
    Uhara, Hisashi
    Kiyohara, Yoshio
    Isei, Taiki
    Nagase, Kotaro
    Kambe, Anzu
    Sato, Masashi
    Tanaka, Yutaro
    Yamazaki, Naoya
    [J]. JOURNAL OF DERMATOLOGY, 2024, 51 (04): : 475 - 483
  • [7] Safety and Effectiveness of Gemcitabine in 855 Patients with Pancreatic Cancer under Japanese Clinical Practice Based on Post-marketing Surveillance in Japan
    Ioka, Tatsuya
    Katayama, Kazuhiro
    Tanaka, Sachiko
    Takakura, Rena
    Ashida, Reiko
    Kobayashi, Noriko
    Taniai, Hisashi
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 139 - 145
  • [8] Safety and Effectiveness of Gemcitabine in 260 Patients with Biliary Tract Cancer in a Japanese Clinical Practice Based on Post-marketing Surveillance in Japan
    Okubo, Sumiko
    Nishiuma, Shinichi
    Kobayashi, Noriko
    Taketsuna, Masanori
    Taniai, Hisashi
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (11) : 1043 - 1053
  • [9] Safety and effectiveness of rasagiline in patients with Parkinson's disease in Japan: a post-marketing surveillance study
    Hattori, Nobutaka
    Kajita, Mika
    Fujimoto, Shinji
    Izutsu, Miwa
    Fernandez, Jovelle
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024, 23 (01) : 79 - 88
  • [10] Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
    Kawasaki, Akira
    Hatake, Kiyohiko
    Matsumura, Itaru
    Izutsu, Koji
    Hoshino, Tomohiro
    Akamatsu, Ayumi
    Kakuuchi, Akito
    Tobinai, Kensei
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (06) : 667 - 676
12345